Cervical cancer: Disease prevention and informational support

Lindsay Ashley Schwartz

Abstract


Cervical cancer and Human Papillomavirus (HPV) are significant health care concerns for women worldwide. Globally, in 2006, cervical cancer remains the second most common cancer in women. Infection with high-risk strains of HPV is found to be present in approximately 99% of cervical cancer cases. The Supportive Care Framework developed by Fitch (2008) will serve as a guide to the paper. The need for informational support and disease prevention initiatives will be explored. Knowledge and awareness of HPV and its link to cervical cancer amongst the general population are low. Once women are made aware of the relationship between HPV and cervical cancer, they want more information on disease prevention, transmission, detection, treatment information, symptoms and risk for developing cancer. Evidence-based nursing interventions that focus on meeting the informational needs of women and increasing awareness of HPV and cervical cancer will be proposed. Information on HPV-prophylactic vaccines and Papanicolaou (PAP) screening as primary and secondary disease prevention strategies will be discussed.


Full Text:

PDF

References


Andy, C., & Turner, L.F. (2004). Is the ThinPrep better than

conventional Pap smear at detecting cervical cancer? Journal of

Family Practice, 53(4), 313–316.

Anhang, R., Goodman, A., & Goldie, S.J. (2004). HPV communication:

Review of existing research and recommendations for patient

education. A Cancer Journal for Clinicians, 54(5), 248–259.

Anhang, R., Stryker, J.E., Wright, T.C, Jr., & Goldie, S.J. (2004). News

media coverage of human papillomavirus. Cancer, 100(2), 308–314.

Brisson, M., Van de Velde, N., De Wals, P., & Boily, M.C. (2007). The

potential cost-effectiveness of prophylactic human papillomavirus

vaccines in Canada. Vaccine, 25, 5399–5408.

Canadian Cancer Society. (2006). Cancer in young adults in

Canada. Retrieved December 5, 2008, from http://www.cancer.ca

Canadian Cancer Society. (2008). Canadian Cancer Statistics.

Retrieved December 5, 2008, from: http://www.cancer.ca

Cancer Care Ontario. (2005). Ontario Cervical Screening Practice

Guidelines. Retrieved March 28, 2008, from

http://www.cancercare.on.ca/documents/CervicalScreening

Guidelines.pdf

Fisher, R., Darrow, D., Tranter, M., & Williams, J. (2008). Human

papillomavirus vaccine: Recommendations, issues and

controversies. Current Opinion in Pediatrics, 20(4), 441–445.

Fitch, M. (1994). Providing Supportive Care for Individuals

Living With Cancer: Report of the Ontario Cancer Treatment

and Research Foundation (OCTRF). Toronto: OCTRF.

Fitch, M. (2000). Supportive care for cancer patients. Hospital

Quarterly, 3(4), 39–46.

Fitch, M. (2008). Supportive Care Framework. Canadian Oncology

Nursing Journal, 18(1), 6–14.

Friedman, A.L., & Shepeard, H. (2007). Exploring the knowledge,

attitudes, beliefs and communication preferences of the general

public regarding HPV: Findings from CDC focus group research

and implications for practice. Health Education & Behavior,

(3), 471–485.

Garland, S.M. (2006). Human papillomavirus vaccines: Challenges to

implementation. Sexual Health, 3, 63–65.

Garland, S.M., & Quinn, M.A. (2006). How to manage and

communicate with patients about HPV? International Journal of

Gynecology and Obstetrics, 94(1), 106–112.

Gerberding, J.L. (2004, January). Report to Congress: Prevention

of genital human papillomavirus infection. Atlanta, GA:

Centers for Disease Control and Prevention, Department of Health

and Human Services.

Gerend, M.A., Cruz Lee, S., & Shepherd, J.E. (2007). Predictors of

human papillomavirus vaccination acceptability among underserved

women. Sexually Transmitted Diseases, 34(7), 466–471.

Giles, M., & Garland, S. (2006). A study of women’s knowledge

regarding human papillomavirus infection, cervical cancer and

human papillomavirus vaccines. Australian and New Zealand

Journal of Obstetrics and Gynecology, 46, 311–315.

Hilton, G.L.S. (2001). Sex education – The issues when working with

boys. Sex Education, 1(1), 31–41.

Kaplan-Myrth, N., & Dollin, J. (2007). Cervical cancer awareness and

HPV prevention in Canada. Canadian Family Physician, 53,

–697.

Koutsky, L. (1997). Epidemiology of genital human papillomavirus

infection. American Journal of Medicine, 102(5A), 3–8.

Logan, J., De Grasse, C.E., Stacey, D., Fiset, V., & Fawcett, L. (1999).

Oncology nursing education within a supportive care framework:

An evidence-based undergraduate course. Canadian Oncology

Nursing Journal, 9(2), 64–66.

Mahon, S.M. (2003). Skin cancer prevention: Education and public

health issues. Seminars in Oncology Nursing, 19(1), 52–61.

Moreira, E.D., Oliveira, B.G., Ferraz, F.M., Costa, S., Costa Filho,

J.O., & Karic, G. (2006). Knowledge and attitudes about human

papillomavirus, pap smears, and cervical cancer among young

women in Brazil: Implications for health education and

prevention. International Journal of Gynecological Cancer, 16,

–603.

Morrison, J.B. (1994). Screening for cervical cancer. Retrieved

October 30, 2007, from the Canadian Task Force on Preventive

Health Care, http: www.ctfphc.org/Full_Text_printable/

Ch73full.htm

Nuovo, J., Melnikow, J., & Howell, L.P. (2001). New tests for

cervical cancer screening. American Family Physician, 64(5),

–786.

Rydstrom, G., & Tornberg, S. (2006). Cervical cancer incidence and

mortality in the best and worst of worlds. Scandinavian Journal

of Public Health, 34, 295–303.

Sankaranarayanan, R., Budukh, A.M., & Rajkumar, R. (2001).

Effective screening programs for cervical cancer in low- and

middle-income developing countries. Bulletin of the World

Health Organization, 79(10), 954–962.

Sawaya, G., & Washington, E.A. (1999). Cervical cancer screening:

Which techniques should be used and why? Clinical obstetrics

and gynecology, 42(4), 922–938.

Shakeshaft, A.P., & Frankish, J.C. (2003). Using patient-driven

computers to provide cost-effective prevention in primary care: A

conceptual framework. Health Promotion International, 18(1),

–77.

Sherris, J., Friedman, A., Wittet, S., Davies, P., Steben, M., & Saraiya,

M. (2006). Education, training, and communication for HPV

vaccines. Vaccine, 24, 210–218.

Squiers, L., Finney Rutten, L.J., Treiman, K., Bright, M.A., & Hesse,

B. (2005). Cancer patients’ information needs across the cancer

care continuum: Evidence from the cancer information services.

Journal of Health Communication, 10(1), 15–34.

Steven, D., Fitch, M., Dhaliwal, H., Kirk-Gardner, R., Sevean, P.,

Jamieson, J., et al. (2004). Knowledge, attitudes, beliefs and

practices regarding breast and cervical cancer screening in selected

ethnocultural groups in northwestern Ontario. Oncology Nursing

Forum, 31(2), 305–311.

Tiffen, J., & Mahon, S.M. (2006). Cervical cancer: What should we

tell women about screening? Clinical Journal of Oncology

Nursing, 10(4), 527–531.

Tiro, J.A., Meissner, H.I., Kobrin, S., & Chollette, V. (2007). What do

women in the U.S. know about human papillomavirus and cervical

cancer? Cancer Epidemiology, Biomarkers & Prevention,

(2), 288–294.

Tristram, A. (2006). HPV information needs. Best Practice &

Research, 20(2), 267–277.

Walboomers, J.M., Jacobs, M.V., Manos, M.M., Bosch, F.X.,

Kummer, J.A., Shah, K.V., et al. (1999). Human papillomavirus is

a necessary cause of invasive cervical cancer worldwide. Journal

of Pathology, 189(1), 12–19.

Wheeler, C.M. (2007). Advances in primary and secondary

interventions for cervical cancer: Human papillomavirus

prophylactic vaccines and testing. Nature Clinical Practice

Oncology, 4(4), 224–235.

World Health Organization. (2006). Comprehensive cervical cancer

control: A guide to essential practice. Retrieved December 5, 2008,

from http://www.who.int/reproductive-health/publications/

cervical_cancer_gep/text.pdf

Yacobi, E., Tennant, C., Ferrante, J., Pal, N., & Roetzheim, R. (1999).

University Students’ knowledge and awareness of HPV.

Preventive Medicine, 28, 535–541.


Refbacks

  • There are currently no refbacks.